Recommendations on bladder cancer Management during COVID-19 pandemia: lessons learned and future plans.

The guidelines and recommendation sof good clinical practice have been disrupted by new and urgent policies, marked by the COVID-19 pandemic. Urothelial carcinoma has a significant prevalence in Spain, whose population has been greatly affected by COVID-19, directly by the disease and indirectly by...

Full description

Saved in:
Bibliographic Details
Published inArchivos españoles de urología Vol. 73; no. 5; p. 374
Main Authors de la Peña, Enrique, Hernández, Virginia, Guijarro, Ana, Castro, Alejandro, Losa, Juan Emilio, Martel, José, Aguilar, Eva, Llorente, Carlos
Format Journal Article
LanguageSpanish
Published Spain 01.06.2020
Subjects
Betacoronavirus
Coronavirus Infections - epidemiology
COVID-19
Humans
Infectious Disease Transmission, Patient-to-Professional
Pandemics
Pneumonia, Viral - epidemiology
SARS-CoV-2
Spain
Urinary Bladder Neoplasms - diagnosis
Urinary Bladder Neoplasms - therapy
Spain
COVID-19
Cáncer de vejiga
SARS-CoV-2
Guías clínicas
Bladder Cáncer
Guidelines
Online AccessGet more information

Cover

More Information
Summary:The guidelines and recommendation sof good clinical practice have been disrupted by new and urgent policies, marked by the COVID-19 pandemic. Urothelial carcinoma has a significant prevalence in Spain, whose population has been greatly affected by COVID-19, directly by the disease and indirectly by the confinement. The objective of this work is to offer recommendations on protocols and guidelines adjusted to different phases of the pandemic. MATERIAL AND METHODS: This document on the management of bladder carcinoma is based on few evidence on urological oncological practice during the first months of the pandemic and on the authors' experience in this pathology during the crisis of COVID-19. Hospital experts in infectious disseases and radiology have participated to design a common strategy to reorganize the activity. RESULTS: Different proposals for treatment and follow-up of patients diagnosed with bladder cancer adjusted for oncological risk and the different phases of the pandemic are presented. CONCLUSIONS: The pandemic's spread was unimaginable just a few months ago. Health systems have been shaken by the disease in the most critical phases. It is necessary, at this time, to make an additional effort to develop tools that can facilitate the care of bladder carcinoma and minimize the impact and risks for patients and health professionals in the future.
ISSN:0004-0614